AxoGen Announces Closing of Public Offering of Common Stock
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/3/2026
- Equities close higher as softer jobs data quiets rate-hike expectations
- U.S. economy adds fewer jobs than expected as unemployment rate ticks higher
- Nvidia returns as Morgan Stanley’s Top Pick on attractive valuation
- Citi says rate volatility without Fed repricing is concerning
- U.S. credit-reporting stocks fall as FHFA weighs two-bureau mortgage rule
- Equities close higher as softer jobs data quiets rate-hike expectations
- Cantor Fitzgerald on Rivian (RIVN): 'pre-announced that it delivered 19,248 vehicles in 3Q26, above our estimate'
- DISH DBS emerges from bankruptcy, cuts debt by $4.35 billion
- Tanker struck by projectile in Strait of Hormuz
- AppLovin shares fall after court denies request against Unity
AxoGen, Inc. (AXGN) PT Raised to $27 at Wedbush Following Investor Day
November 21, 2017 9:44 AM ESTWedbush raised its price target on AxoGen, Inc. (NASDAQ: AXGN) to $27.00 (from $22.00) while maintaining a Outperform rating following the company's investor day. Analyst Tao Levy came away with greater confidence and clarity around the company's new market opportunities within peripheral nerve repair.
Management... More
AxoGen, Inc. (AXGN) PT Raised to $27 at JMP Securities Following Analyst Day
November 21, 2017 8:04 AM ESTJMP Securities raised its price target on AxoGen, Inc. (NASDAQ: AXGN) to $27.00 (from $25.00) while maintaining a Market Outperform rating following the company's analyst day. JMP's new $27 target is based on 8-9x EV/Sales on 2019 revenue estimates of $105 mln.
The company continued... More
